Sagimet Biosciences Inc Series A Common Stock
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -18,195 | -16,902 | -10,589 | -8,768 |
EBIT | -21,178 | -17,536 | ||
Net Income | -16,201 | -14,619 | -8,118 | -6,629 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,024 | -19,569 | -5,634 | -6,208 |
Cash | 75,840 | 77,014 | 95,959 | 176,777 |
Basic Shares | 32,195 | 32,143 | 31,913 | 29,039 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $2,000 | $0 | $0 |
Gross Profit | 2,000 | -130 | -134 | |
EBITDA | -54,454 | -30,740 | -31,055 | -23,719 |
EBIT | -61,484 | -31,055 | -23,719 | |
Net Income | -45,567 | -27,876 | -30,499 | -24,442 |
Net Change In Cash | 0 | 2,000 | 0 | 0 |
Free Cash Flow | -42,435 | -23,766 | -24,490 | -21,710 |
Cash | 75,840 | 75,139 | 158 | 56,731 |
Basic Shares | 31,350 | 10,460 | 22,174 | 22,174 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.50 |
2024-09-30 | -$0.45 |
2024-06-30 | -$0.25 |
2024-03-31 | -$0.23 |
